Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival.

Breunig IM, Shaya FT, Hanna N, Seal B, Chirikov VV, Daniel Mullins C.

Value Health. 2013 Jul-Aug;16(5):760-8. doi: 10.1016/j.jval.2013.03.1630. Epub 2013 May 28.

2.

Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.

Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N.

Pharmacoeconomics. 2014 Jan;32(1):63-74. doi: 10.1007/s40273-013-0109-7.

PMID:
24293197
3.

Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries.

Sanoff HK, Chang Y, Stavas JM, Stürmer T, Lund J.

J Natl Compr Canc Netw. 2015 Sep;13(9):1102-10.

4.

Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.

Heng-jun G, Yao-jun Z, Min-shan C, Mei-xian C, Jun-ting H, Li X, Lau WY.

Liver Int. 2014 Apr;34(4):612-20. doi: 10.1111/liv.12307. Epub 2013 Sep 13.

PMID:
24028297
5.

The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.

Lee KT, Lu YW, Wang SN, Chen HY, Chuang SC, Chang WT, Shi HY, Ker CG, Chiu HC.

J Surg Oncol. 2009 May 1;99(6):343-50. doi: 10.1002/jso.21248.

PMID:
19226530
6.

Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.

Hsu KF, Chu CH, Chan DC, Yu JC, Shih ML, Hsieh HF, Hsieh TY, Yu CY, Hsieh CB.

Eur J Radiol. 2012 Mar;81(3):466-71. doi: 10.1016/j.ejrad.2010.12.058. Epub 2011 Mar 3.

PMID:
21376495
7.

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.

Pinter M, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Stauber R, Grünberger B, Müller C, Kölblinger C, Peck-Radosavljevic M, Sieghart W.

Radiology. 2012 May;263(2):590-9. doi: 10.1148/radiol.12111550. Epub 2012 Mar 21.

PMID:
22438359
8.

Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.

Rostambeigi N, Dekarske AS, Austin EE, Golzarian J, Cressman EN.

J Vasc Interv Radiol. 2014 Jul;25(7):1075-84. doi: 10.1016/j.jvir.2014.04.014. Epub 2014 May 24. Review.

PMID:
24861664
9.

Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.

Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.

J Gastroenterol Hepatol. 2009 Aug;24(8):1437-44. doi: 10.1111/j.1440-1746.2009.05863.x. Epub 2009 May 28.

PMID:
19486255
10.

Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.

Davila JA, Duan Z, McGlynn KA, El-Serag HB.

J Clin Gastroenterol. 2012 Jan;46(1):71-7. doi: 10.1097/MCG.0b013e318224d669.

11.

Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization.

Yu SJ, Lee JH, Jang ES, Cho EJ, Kwak MS, Yoon JH, Lee HS, Kim CY, Kim YJ.

Radiology. 2013 May;267(2):638-47. doi: 10.1148/radiol.13121498. Epub 2013 Feb 25.

PMID:
23440326
12.

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y; Liver Cancer Study Group of Japan.

Gastroenterology. 2006 Aug;131(2):461-9.

PMID:
16890600
13.

Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.

Cabibbo G, Genco C, Di Marco V, Barbara M, Enea M, Parisi P, Brancatelli G, Romano P, Craxì A, Cammà C.

Aliment Pharmacol Ther. 2011 Jul;34(2):196-204. doi: 10.1111/j.1365-2036.2011.04694.x. Epub 2011 May 12.

14.

Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.

Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.

J Nucl Med. 2009 Jun;50(6):871-7. doi: 10.2967/jnumed.108.060558. Epub 2009 May 14.

15.

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, Ayuso C, Llovet JM, Real MI, Bruix J.

J Hepatol. 2012 Jun;56(6):1330-5. doi: 10.1016/j.jhep.2012.01.008. Epub 2012 Feb 5.

PMID:
22314428
16.

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.

El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA.

J Hepatol. 2006 Jan;44(1):158-66. Epub 2005 Nov 2.

PMID:
16290309
17.

Transarterial chemoembolization in patients with hepatocellular carcinoma: predictors of survival.

Sawhney S, Montano-Loza AJ, Salat P, McCarthy M, Kneteman N, Meza-Junco J, Owen R.

Can J Gastroenterol. 2011 Aug;25(8):426-32.

18.

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.

Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

J Gastroenterol Hepatol. 2009 May;24(5):806-14. doi: 10.1111/j.1440-1746.2008.05728.x. Epub 2009 Jan 13.

PMID:
19207681
19.

Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.

Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Pai JT, Loong CC, Chiou YY, Lee RC, Lee FY, Huo TI, Lee SD.

Ann Surg Oncol. 2012 Mar;19(3):842-9. doi: 10.1245/s10434-011-2060-1. Epub 2011 Sep 13.

PMID:
21913008
20.

Supplemental Content

Support Center